EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel treatment approach for cold agglutinin induced acute hemolytic anemia

Sara Dichtwald, Avraham Meyer, Ilana Hellmann, Nisim Ifrach, Martin Ellis

Clinical Hematology International: Case Reports · 26.10.2026 · 1 (4)

DOI: 10.46989/001c.172556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Hematology International: Case Reports, online erschienen am 26.10.2026. Verfasst von Sara Dichtwald und 4 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cold autoimmune hemolytic anemia (AIHA) is caused by cold-reactive IgM autoantibodies, also known as cold agglutinins, which bind to red blood cells at cold temperatures. It may be either primary or secondary to infection, drugs, or lymphoproliferative disease. While hemolysis may be extravascular, severe intravascular complement-mediated hemolysis may occur. Goals of therapy include maintaining a stable hemoglobin level and treating the underlying etiology. Complement inhibitors may be used in severe or refractory cases. Case presentation We describe a case of fulminant cold AIHA in which complement inhibition and extracorporeal warming of the patient’s blood with Prismaflex® continuous veno-venous extracorporeal circulation were used as an emergency measure with rapid control of hemolysis, as was evidenced by resolution of acrocyanosis and improvement in hemodynamic parameters and stabilization of hemoglobin without need for further blood transfusions.

Conclusion

To our knowledge, this is the first report of the combined use of extracorporeal blood warming and complement inhibition as a rescue measure for massive cold AIHA. We suggest that this strategy may represent a rescue option in selected life-threatening cases when routine warming of the patient is insufficient to abrogate the acute hemolytic process and until definitive therapy becomes effective and the autoimmune process resolves.

Zitieren

APA

Dichtwald, S., Meyer, A., Hellmann, I., Ifrach, N., & Ellis, M. (2026). A novel treatment approach for cold agglutinin induced acute hemolytic anemia. Clinical Hematology International: Case Reports, 1(4). https://doi.org/10.46989/001c.172556

Vancouver

Dichtwald S, Meyer A, Hellmann I, Ifrach N, Ellis M. A novel treatment approach for cold agglutinin induced acute hemolytic anemia. Clinical Hematology International: Case Reports. 2026;1(4). doi:10.46989/001c.172556

BibTeX
@article{Dichtwald2026,
  author = {Dichtwald, Sara and Meyer, Avraham and Hellmann, Ilana and Ifrach, Nisim and Ellis, Martin},
  title = {A novel treatment approach for cold agglutinin induced acute hemolytic anemia},
  journal = {Clinical Hematology International: Case Reports},
  year = {2026},
  volume = {1},
  number = {4},
  doi = {10.46989/001c.172556}
}
Kostenlos starten →